Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors
Clinical trial NCT03875287 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03875287
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-17
- Primary completion
- 2026-09-02
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.